Learn more about our COVID-19 vaccine study for healthy adults and adolescents 12 years and older.
Who can take part in the study
This study is enrolling people who:
- Are [at least 12] years old
- Are generally healthy or have stable chronic conditions and no history of myocarditis or pericarditis
- If previously vaccinated, have not received a COVID-19 vaccine within the last 5 months (150 days)
There are other study requirements that the study team will discuss with you.
Participation matters
Participation by people of all backgrounds is critical to developing vaccines that protect against infectious diseases [like COVID-19].
The greater the diversity among clinical trial participants, the more we can learn about potential vaccines and how they work for different people, including those most at-risk because of their age, race, ethnicity, or where and how they live. Each new vaccine breakthrough helps us reach more people to prevent and reduce the spread of disease.
Your time in the study
All participants will receive a single dose of the study vaccine. This study does not include a placebo (injection with no active ingredient).
After you receive your study vaccine, the study team will perform some tests and monitor your health periodically.
How long will participants be in this research study?
- About six months
How many study visits are required?
- At least five visits
Your safety is the top priority
Safety is always the top priority of any research study. Before you join the study, you will be given all the details about participation, including potential benefits and risks. Your health will be carefully monitored throughout the study by the study team.
Volunteering is your choice
Choosing to volunteer for a clinical trial is very personal, and many factors may weigh in your decision-making. To decide if this research study is a good fit, it’s important to understand the process and what is required. If you would like to participate, you will provide your consent (permission) before joining the study. You are also free to stop being in the study at any time, for any reason.
Study-related costs are covered
The study vaccines and study-related procedures will be provided at no cost. You will also be reimbursed for any study related expenses.
An important contribution
Staying up to date on your COVID-19 vaccines is still the best way to protect yourself and others from serious illness. However, as the virus continues to change, vaccines must evolve as well. For this reason, we are looking for ways to make the 2024-2025 season’s COVID-19 vaccine more effective against the newest variants.
Your participation in this clinical trial will contribute to the development of an updated COVID-19 vaccine that may increase protection for millions of people around the world. So, thank you for taking the time to learn more.
About the study
This study will help us learn if an investigational formulation of our COVID-19 vaccine is safe, and if it can help the body produce antibodies to fight off a new variant of COVID-19 predicted to be the most common during the 2024-2025 respiratory virus season.
The study vaccine is a modified version of Pfizer-BioNTech’s original mRNA-based COVID-19 vaccine, which has been authorized for use in more than 149 countries. The modified formulation is designed to improve protection against a variant responsible for the majority of new cases of COVID-19 called Omicron JN.1.
Ready to learn more?
Contact the study team: 786-772-0510
